Mustafa O. Guler

@mustafaoguler.bsky.social

Biomaterials, Bioengineering, Nanomedicine, Nanomaterials, Fellow @RoySocChem, Ed. Brd. Mb. @ACSBiomaterials @SciReports, Professor @UChicago @UChicagoPME

3D multi-omics tumour atlases: from technology to biology and clinical translation Read this Nature Reviews Cancer paper here:https://www.nature.com/articles/s41568-026-00940-0

Bild

Comment in @nature.com: "Food will be more affordable — if we double funds for agriculture research now" www.nature.com/articles/d41... A global drop in public and private investment in agricultural science in the past four decades is partly to blame for high food prices, an analysis reveals.

Food will be more affordable — if we double funds for agriculture research now

A global drop in public and private investment in agricultural science in the past four decades is partly to blame for high food prices, an analysis reveals.

nature.com

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts say semaglutide drugs will become cheaper and more accessible for patients with diabetes and obesity. cen.acs.org/pharmaceutic... #chemsky 🧪

Nozempic? A look at what will happen when GLP-1 drugs go off patent in some countries next year

India and China are among the countries where knockoffs of Wegovy and Ozempic can be sold next year

cen.acs.org